ID   CDK16_HUMAN             Reviewed;         496 AA.
AC   Q00536; A8K280; B7Z7C8; J3KN74; J3KQP7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   15-MAR-2017, entry version 175.
DE   RecName: Full=Cyclin-dependent kinase 16;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 16;
DE   AltName: Full=PCTAIRE-motif protein kinase 1;
DE   AltName: Full=Serine/threonine-protein kinase PCTAIRE-1;
GN   Name=CDK16; Synonyms=PCTAIRE1, PCTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=1639063;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78; SER-82; SER-95;
RP   SER-119 AND SER-138, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138; SER-153 AND
RP   SER-155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42; SER-78; SER-82;
RP   SER-95; SER-119 AND SER-138, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119 AND SER-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH CCNY.
RX   PubMed=22796189; DOI=10.1016/j.cellsig.2012.06.018;
RA   Shehata S.N., Hunter R.W., Ohta E., Peggie M.W., Lou H.J., Sicheri F.,
RA   Zeqiraj E., Turk B.E., Sakamoto K.;
RT   "Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1
RT   kinase.";
RL   Cell. Signal. 24:2085-2094(2012).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH BRSK2, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF SER-12; SER-153 AND LYS-194, PHOSPHORYLATION
RP   AT SER-12, AND TISSUE SPECIFICITY.
RX   PubMed=22798068; DOI=10.1074/jbc.M112.375618;
RA   Chen X.Y., Gu X.T., Saiyin H., Wan B., Zhang Y.J., Li J., Wang Y.L.,
RA   Gao R., Wang Y.F., Dong W.P., Najjar S.M., Zhang C.Y., Ding H.F.,
RA   Liu J.O., Yu L.;
RT   "Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1
RT   negatively regulates glucose-stimulated insulin secretion in
RT   pancreatic beta-cells.";
RL   J. Biol. Chem. 287:30368-30375(2012).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   CCNY, AND MUTAGENESIS OF SER-119; SER-153 AND LYS-194.
RX   PubMed=22184064; DOI=10.1128/MCB.06261-11;
RA   Mikolcevic P., Sigl R., Rauch V., Hess M.W., Pfaller K., Barisic M.,
RA   Pelliniemi L.J., Boesl M., Geley S.;
RT   "Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y
RT   and is essential for spermatogenesis.";
RL   Mol. Cell. Biol. 32:868-879(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-65; SER-95;
RP   SER-138; SER-153 AND SER-155, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 163-478.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the PCTAIRE1 kinase in complex with indirubin
RT   e804.";
RL   Submitted (JUN-2010) to the PDB data bank.
CC   -!- FUNCTION: Protein kinase that plays a role in vesicle-mediated
CC       transport processes and exocytosis. Regulates GH1 release by brain
CC       neurons. Phosphorylates NSF, and thereby regulates NSF
CC       oligomerization. Required for normal spermatogenesis. Regulates
CC       neuron differentiation and dendrite development (By similarity).
CC       Plays a role in the regulation of insulin secretion in response to
CC       changes in blood glucose levels. Can phosphorylate CCNY at 'Ser-
CC       336' (in vitro). {ECO:0000250, ECO:0000269|PubMed:22184064,
CC       ECO:0000269|PubMed:22796189, ECO:0000269|PubMed:22798068}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189,
CC       ECO:0000269|PubMed:22798068}.
CC   -!- SUBUNIT: Found in a complex containing CABLES1, CDK17 and TDRD7.
CC       Interacts with YWHAH, YWHAQ and YWHAZ. Interacts with NSF.
CC       Identified in a complex with NSF, syntaxin-1, synaptotagmin, SYN1,
CC       SYP and CDK5R1 (By similarity). Interacts with BRSK2. Interacts
CC       with CCNY; this increases the CDK16 kinase activity. {ECO:0000250,
CC       ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189,
CC       ECO:0000269|PubMed:22798068}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-726261, EBI-743771;
CC       Q8ND76-1:CCNY; NbExp=7; IntAct=EBI-726261, EBI-11615526;
CC       Q8N7R7:CCNYL1; NbExp=3; IntAct=EBI-726261, EBI-10103094;
CC       Q15436:SEC23A; NbExp=3; IntAct=EBI-726261, EBI-81088;
CC       O43829:ZBTB14; NbExp=3; IntAct=EBI-726261, EBI-10176632;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle, secretory
CC       vesicle. Cell membrane; Peripheral membrane protein; Cytoplasmic
CC       side. Cell junction, synapse, synaptosome {ECO:0000250}.
CC       Note=Colocalizes with insulin in pancreas islets. Recruited to the
CC       cell membrane by CCNY.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q00536-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00536-2; Sequence=VSP_046134;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q00536-3; Sequence=VSP_046342;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in pancreas islets (at protein
CC       level). Detected in brain and pancreas.
CC       {ECO:0000269|PubMed:22798068}.
CC   -!- PTM: Phosphorylation at Ser-153 inhibits kinase activity.
CC       {ECO:0000269|PubMed:22798068}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01048.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH15607.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66363; CAA47006.1; -; mRNA.
DR   EMBL; BT006827; AAP35473.1; -; mRNA.
DR   EMBL; AK290145; BAF82834.1; -; mRNA.
DR   EMBL; AK301832; BAH13564.1; -; mRNA.
DR   EMBL; AL096791; CAD20055.1; -; Genomic_DNA.
DR   EMBL; AL513366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471164; EAW59295.1; -; Genomic_DNA.
DR   EMBL; CH471164; EAW59297.1; -; Genomic_DNA.
DR   EMBL; BC001048; AAH01048.1; ALT_INIT; mRNA.
DR   EMBL; BC015607; AAH15607.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14276.1; -. [Q00536-1]
DR   CCDS; CCDS48101.1; -. [Q00536-3]
DR   CCDS; CCDS55408.1; -. [Q00536-2]
DR   PIR; S23385; S23385.
DR   RefSeq; NP_001163931.1; NM_001170460.1. [Q00536-2]
DR   RefSeq; NP_006192.1; NM_006201.4. [Q00536-1]
DR   RefSeq; NP_148978.2; NM_033018.3. [Q00536-3]
DR   RefSeq; XP_016885059.1; XM_017029570.1. [Q00536-1]
DR   RefSeq; XP_016885060.1; XM_017029571.1. [Q00536-1]
DR   RefSeq; XP_016885061.1; XM_017029572.1. [Q00536-1]
DR   RefSeq; XP_016885062.1; XM_017029573.1. [Q00536-1]
DR   UniGene; Hs.496068; -.
DR   PDB; 3MTL; X-ray; 2.40 A; A=163-478.
DR   PDB; 5G6V; X-ray; 2.20 A; A/B=163-478.
DR   PDBsum; 3MTL; -.
DR   PDBsum; 5G6V; -.
DR   ProteinModelPortal; Q00536; -.
DR   SMR; Q00536; -.
DR   BioGrid; 111154; 40.
DR   IntAct; Q00536; 29.
DR   STRING; 9606.ENSP00000276052; -.
DR   BindingDB; Q00536; -.
DR   ChEMBL; CHEMBL4597; -.
DR   GuidetoPHARMACOLOGY; 1969; -.
DR   iPTMnet; Q00536; -.
DR   PhosphoSitePlus; Q00536; -.
DR   BioMuta; CDK16; -.
DR   DMDM; 266425; -.
DR   EPD; Q00536; -.
DR   MaxQB; Q00536; -.
DR   PaxDb; Q00536; -.
DR   PeptideAtlas; Q00536; -.
DR   PRIDE; Q00536; -.
DR   DNASU; 5127; -.
DR   Ensembl; ENST00000276052; ENSP00000276052; ENSG00000102225. [Q00536-2]
DR   Ensembl; ENST00000357227; ENSP00000349762; ENSG00000102225. [Q00536-1]
DR   Ensembl; ENST00000457458; ENSP00000405798; ENSG00000102225. [Q00536-3]
DR   Ensembl; ENST00000518022; ENSP00000429751; ENSG00000102225. [Q00536-1]
DR   GeneID; 5127; -.
DR   KEGG; hsa:5127; -.
DR   UCSC; uc004dho.4; human. [Q00536-1]
DR   CTD; 5127; -.
DR   DisGeNET; 5127; -.
DR   GeneCards; CDK16; -.
DR   HGNC; HGNC:8749; CDK16.
DR   HPA; CAB016535; -.
DR   HPA; HPA000974; -.
DR   HPA; HPA001366; -.
DR   MIM; 311550; gene.
DR   neXtProt; NX_Q00536; -.
DR   OpenTargets; ENSG00000102225; -.
DR   PharmGKB; PA33095; -.
DR   eggNOG; KOG0594; Eukaryota.
DR   eggNOG; ENOG410XPP3; LUCA.
DR   GeneTree; ENSGT00790000122986; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q00536; -.
DR   KO; K08820; -.
DR   OMA; PMAGPIT; -.
DR   OrthoDB; EOG091G0CH0; -.
DR   PhylomeDB; Q00536; -.
DR   TreeFam; TF106508; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q00536; -.
DR   SIGNOR; Q00536; -.
DR   ChiTaRS; CDK16; human.
DR   GeneWiki; PCTK1; -.
DR   GenomeRNAi; 5127; -.
DR   PRO; PR:Q00536; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102225; -.
DR   CleanEx; HS_PCTK1; -.
DR   ExpressionAtlas; Q00536; baseline and differential.
DR   Genevisible; Q00536; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; ISS:UniProtKB.
DR   GO; GO:0030252; P:growth hormone secretion; ISS:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell junction;
KW   Cell membrane; Complete proteome; Cytoplasm; Cytoplasmic vesicle;
KW   Differentiation; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Spermatogenesis;
KW   Synapse; Synaptosome; Transferase.
FT   CHAIN         1    496       Cyclin-dependent kinase 16.
FT                                /FTId=PRO_0000086484.
FT   DOMAIN      165    446       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     171    179       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    286    286       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     194    194       ATP. {ECO:0000305}.
FT   MOD_RES      12     12       Phosphoserine; by BRSK2.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:22798068}.
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      78     78       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES      95     95       Phosphoserine; by CDK5.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     110    110       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63686}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     155    155       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      1       M -> MPLYGRARDHVTHPSILGTRPGRPMAGPITAAVPEK
FT                                ICNGAFCSCSGAFPLDPNNPSLGPLPSISHLNLRTQIAM
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046134.
FT   VAR_SEQ       1      1       M -> MQSEIAM (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046342.
FT   MUTAGEN      12     12       S->A: Abolishes phosphorylation by BRSK2.
FT                                Abolishes effect on insulin secretion.
FT                                {ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     119    119       S->A: Strongly reduces interaction with
FT                                CCNY. {ECO:0000269|PubMed:22184064}.
FT   MUTAGEN     153    153       S->A: Constitutively activated, due to
FT                                loss of an inhibitory phosphorylation
FT                                site. Increases interaction with CCNY.
FT                                {ECO:0000269|PubMed:22184064,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     153    153       S->D: Abolishes interaction with CCNY.
FT                                {ECO:0000269|PubMed:22184064,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     194    194       K->A: Loss of kinase activity. Abolishes
FT                                effect on insulin secretion.
FT                                {ECO:0000269|PubMed:22184064,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     194    194       K->R: Loss of kinase activity.
FT                                {ECO:0000269|PubMed:22184064,
FT                                ECO:0000269|PubMed:22798068}.
FT   CONFLICT     25     25       N -> D (in Ref. 3; BAH13564).
FT                                {ECO:0000305}.
FT   STRAND      165    173       {ECO:0000244|PDB:5G6V}.
FT   STRAND      175    184       {ECO:0000244|PDB:5G6V}.
FT   TURN        185    187       {ECO:0000244|PDB:5G6V}.
FT   STRAND      190    197       {ECO:0000244|PDB:5G6V}.
FT   HELIX       206    217       {ECO:0000244|PDB:5G6V}.
FT   STRAND      226    231       {ECO:0000244|PDB:5G6V}.
FT   STRAND      233    241       {ECO:0000244|PDB:5G6V}.
FT   STRAND      244    246       {ECO:0000244|PDB:5G6V}.
FT   HELIX       247    253       {ECO:0000244|PDB:5G6V}.
FT   TURN        254    256       {ECO:0000244|PDB:5G6V}.
FT   HELIX       260    279       {ECO:0000244|PDB:5G6V}.
FT   STRAND      282    286       {ECO:0000244|PDB:3MTL}.
FT   HELIX       289    291       {ECO:0000244|PDB:5G6V}.
FT   STRAND      292    294       {ECO:0000244|PDB:5G6V}.
FT   STRAND      300    302       {ECO:0000244|PDB:5G6V}.
FT   STRAND      304    309       {ECO:0000244|PDB:3MTL}.
FT   TURN        324    327       {ECO:0000244|PDB:5G6V}.
FT   TURN        330    335       {ECO:0000244|PDB:5G6V}.
FT   HELIX       342    357       {ECO:0000244|PDB:5G6V}.
FT   HELIX       367    378       {ECO:0000244|PDB:5G6V}.
FT   TURN        383    385       {ECO:0000244|PDB:5G6V}.
FT   HELIX       389    391       {ECO:0000244|PDB:5G6V}.
FT   HELIX       393    397       {ECO:0000244|PDB:5G6V}.
FT   HELIX       408    411       {ECO:0000244|PDB:5G6V}.
FT   HELIX       417    426       {ECO:0000244|PDB:5G6V}.
FT   HELIX       431    433       {ECO:0000244|PDB:5G6V}.
FT   HELIX       437    441       {ECO:0000244|PDB:5G6V}.
FT   HELIX       444    449       {ECO:0000244|PDB:5G6V}.
FT   HELIX       452    455       {ECO:0000244|PDB:5G6V}.
FT   HELIX       462    465       {ECO:0000244|PDB:5G6V}.
SQ   SEQUENCE   496 AA;  55716 MW;  9A5DDD34A5E5CBBB CRC64;
     MDRMKKIKRQ LSMTLRGGRG IDKTNGAPEQ IGLDESGGGG GSDPGEAPTR AAPGELRSAR
     GPLSSAPEIV HEDLKMGSDG ESDQASATSS DEVQSPVRVR MRNHPPRKIS TEDINKRLSL
     PADIRLPEGY LEKLTLNSPI FDKPLSRRLR RVSLSEIGFG KLETYIKLDK LGEGTYATVY
     KGKSKLTDNL VALKEIRLEH EEGAPCTAIR EVSLLKDLKH ANIVTLHDII HTEKSLTLVF
     EYLDKDLKQY LDDCGNIINM HNVKLFLFQL LRGLAYCHRQ KVLHRDLKPQ NLLINERGEL
     KLADFGLARA KSIPTKTYSN EVVTLWYRPP DILLGSTDYS TQIDMWGVGC IFYEMATGRP
     LFPGSTVEEQ LHFIFRILGT PTEETWPGIL SNEEFKTYNY PKYRAEALLS HAPRLDSDGA
     DLLTKLLQFE GRNRISAEDA MKHPFFLSLG ERIHKLPDTT SIFALKEIQL QKEASLRSSS
     MPDSGRPAFR VVDTEF
//
